LncRNA Taurine-Upregulated Gene 1 Promotes Cell Proliferation by Inhibiting MicroRNA-9 in MCF-7 Cells

다국어 초록 (Multilingual Abstract)

Purpose: This study was designed to investigate the role of taurine- upregulated gene 1 (TUG1) in MCF-7 breast cancer cells and the molecular mechanism involved in the regulation of microRNA- 9 (miR-9). Methods: The expression of TUG1 in breast cancer tissues and cells was evaluated using quantitative reverse transcription polymerase chain reaction. Cell viability was examined using a 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-Htetrazolium bromide (MTT) assay; cell cycle progression and apoptosis were analyzed using flow cytometry. A dual luciferase reporter assay was used to detect the relationship between TUG1 and miR-9. The expression of methylenetetrahydrofolate dehydrogenase 2 (MTHFD2) was measured by western blot.
Results: Higher expression of TUG1 was observed in breast cancer tissues and cell lines than in the corresponding controls.
TUG1 knockdown reduced proliferation, suppressed cell cycle progression, and promoted apoptosis of MCF-7 cells. The dual luciferase reporter assay showed that TUG1 could negatively regulate the expression of miR-9. MiR-9 inhibition abrogated the effect of TUG1 knockdown on the proliferation, cell cycle progression, and apoptosis of MCF-7 cells. TUG1 positively regulated the expression of MTHFD2 in breast cancer cells.
Conclusion: TUG1 knockdown was significantly associated with decreased cell proliferation and it promoted apoptosis of breast cancer cells through the regulation of miR-9.

참고문헌 (Reference)

1 Lu J, "miR-9 targets CXCR4 and functions as a potential tumor suppressor in nasopharyngeal carcinoma" 35 : 554-563, 2014

2 Wang H, "miR-9 promotes cell proliferation and inhibits apoptosis by targeting LASS2 in bladder cancer" 36 : 9631-9640, 2015

3 Ma B, "Upregulation of long non-coding RNA TUG1 correlates with poor prognosis and disease status in osteosarcoma" 37 : 4445-4455, 2016

4 Young TL, "The noncoding RNA taurine upregulated gene 1 is required for differentiation of the murine retina" 15 : 501-512, 2005

5 Sun J, "The long non-coding RNA TUG1 indicates a poor prognosis for colorectal cancer and promotes metastasis by affecting epithelial-mesenchymal transition" 14 : 42-, 2016

6 Kallen AN, "The imprinted H19 lncRNA antagonizes let-7 microRNAs" 52 : 101-112, 2013

7 Gibb EA, "The functional role of long non-coding RNA in human carcinomas" 10 : 38-, 2011

8 Mandal CC, "Simvastatin prevents skeletal metastasis of breast cancer by an antagonistic interplay between p53 and CD44" 286 : 11314-11327, 2011

9 Yan S, "Prognostic significance of c-Met in breast cancer: a meta-analysis of 6010 cases" 10 : 62-, 2015

10 Zhang EB, "P53-regulated long non-coding RNA TUG1 affects cell proliferation in human non-small cell lung cancer, partly through epigenetically regulating HOXB7 expression" 5 : e1243-, 2014

11 Wang J, "Overexpressions of microRNA-9 and microRNA-200c in human breast cancers are associated with lymph node metastasis" 28 : 283-288, 2013

12 Im JH, "New evidence of lncRNA role in tumor progression and metastasis" 1 : 55-56, 2012

13 Ke H, "NEAT1 is required for survival of breast cancer cells through FUS and miR-548" 10 (10): 11-17, 2016

14 Bartel DP, "MicroRNAs: genomics, biogenesis, mechanism, and function" 116 : 281-297, 2004

15 Gwak JM, "MicroRNA-9 is associated with epithelial-mesenchymal transition, breast cancer stem cell phenotype, and tumor progression in breast cancer" 147 : 39-49, 2014

16 Selcuklu SD, "MicroRNA-9 inhibition of cell proliferation and identification of novel miR-9 targets by transcriptome profiling in breast cancer cells" 287 : 29516-29528, 2012

17 Zhou X, "MicroRNA-9 as potential biomarker for breast cancer local recurrence and tumor estrogen receptor status" 7 : e39011-, 2012

18 Tuo YL, "Long noncoding RNA UCA1 modulates breast cancer cell growth and apoptosis through decreasing tumor suppressive miR-143" 19 : 3403-3411, 2015

19 Li J, "LncRNA TUG1 acts as a tumor suppressor in human glioma by promoting cell apoptosis" 241 : 644-649, 2016

20 Xing Z, "LncRNA BCAR4 wires up signaling transduction in breast cancer" 12 : 681-689, 2015

21 Zhang E, "Increased expression of long noncoding RNA TUG1 predicts a poor prognosis of gastric cancer and regulates cell proliferation by epigenetically silencing of p57" 7 : e2109-, 2016

22 Liu F, "Increased MTHFD2 expression is associated with poor prognosis in breast cancer" 35 : 8685-8690, 2014

23 O’Brien KM, "Hormone therapy and young-onset breast cancer" 181 : 799-807, 2015

24 Jadaliha M, "Functional and prognostic significance of long non-coding RNA MALAT1as a metastasis driver in ER negative lymph node negative breast cancer" 7 : 40418-40436, 2016

25 Xu S, "Downregulation of long noncoding RNA MALAT1 induces epithelial-to-mesenchymal transition via the PI3K-AKT pathway in breast cancer" 8 : 4881-4891, 2015

26 Zhang Q, "Down-regulation of long non-coding RNA TUG1 inhibits osteosarcoma cell proliferation and promotes apoptosis" 14 : 2311-2315, 2013

27 Shuvalov O, "Current genome editing tools in gene therapy: new approaches to treat cancer" 15 : 511-529, 2015

28 Han L, "Circulating long noncoding RNA GAS5as a potential biomarker in breast cancer for assessing the surgical effects" 37 : 6847-6854, 2016

29 Krichevsky AM, "A microRNA array reveals extensive regulation of microRNAs during brain development" 9 : 1274-1281, 2003